Xofluza Den europeiske union - norsk - EMA (European Medicines Agency)

xofluza

roche registration gmbh - baloxavir marboxil - influensa, human - antivirale midler til systemisk bruk - treatment of influenzaxofluza is indicated for the treatment of uncomplicated influenza in patients aged 1 year and above. post exposure prophylaxis of influenzaxofluza is indicated for post-exposure prophylaxis of influenza in individuals aged 1 year and above. xofluza should be used in accordance with official recommendations.

Ozawade Den europeiske union - norsk - EMA (European Medicines Agency)

ozawade

bioprojet pharma - pitolisant - sleep apnea, obstructive - andre nervesystemet narkotika - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).

Wakix 4.5 mg Norge - norsk - Statens legemiddelverk

wakix 4.5 mg

paranova as - pitolisanthydroklorid - tablett, filmdrasjert - 4.5 mg

Wakix 18 mg Norge - norsk - Statens legemiddelverk

wakix 18 mg

paranova as - pitolisanthydroklorid - tablett, filmdrasjert - 18 mg

Palexia depot 50 mg Norge - norsk - Statens legemiddelverk

palexia depot 50 mg

orifarm as - tapentadolhydroklorid - depottablett - 50 mg

Palexia depot 100 mg Norge - norsk - Statens legemiddelverk

palexia depot 100 mg

orifarm as - tapentadolhydroklorid - depottablett - 100 mg

Palexia depot 150 mg Norge - norsk - Statens legemiddelverk

palexia depot 150 mg

orifarm as - tapentadolhydroklorid - depottablett - 150 mg

Palexia depot 200 mg Norge - norsk - Statens legemiddelverk

palexia depot 200 mg

orifarm as - tapentadolhydroklorid - depottablett - 200 mg